ストックスクリーナーアプリを入手
10.32
2.89%
0.29
アフターアワーズ：
10.50
0.18
+1.74%
前日終値:
$10.03
開ける：
$10
24時間の取引高:
280.59K
Relative Volume:
0.49
時価総額：
$501.43M
収益：
$251.00K
当期純損益:
$-87.07M
株価収益率:
-2.9075
EPS:
-3.5494
ネットキャッシュフロー:
$-80.18M
1週間 パフォーマンス:
+12.79%
1か月 パフォーマンス:
+7.28%
6か月 パフォーマンス:
+112.78%
1年 パフォーマンス:
+186.67%
1日の値動き範囲:
$9.93
$10.68
1週間の範囲:
$9.0435
$11.30
52週間の値動き範囲:
$2.22
$14.53
Artiva Biotherapeutics Inc Stock (ARTV) Company Profile
名前
Artiva Biotherapeutics Inc
セクター
電話
(858) 267-4467
住所
5505 MOREHOUSE DRIVE, SAN DIEGO
Compare ARTV vs VRTX, REGN, ARGX, RVMD, ALNY
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
ARTV
Artiva Biotherapeutics Inc
|
10.32 | 487.34M | 251.00K | -87.07M | -80.18M | -3.5494 |
VRTX
Vertex Pharmaceuticals Inc
|
479.00 | 121.16B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
667.17 | 68.78B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
888.82 | 57.44B | 4.16B | 1.29B | 734.26M | 19.58 |
RVMD
Revolution Medicines Inc
|
188.07 | 40.23B | 742.00K | -1.37B | -1.07B | -7.0731 |
ALNY
Alnylam Pharmaceuticals Inc
|
278.40 | 36.28B | 4.29B | 577.22M | 641.34M | 4.2086 |
Artiva Biotherapeutics Inc Stock (ARTV) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-06-11 | 再開されました | H.C. Wainwright | Buy |
| 2024-12-30 | 開始されました | H.C. Wainwright | Buy |
| 2024-08-13 | 開始されました | Cantor Fitzgerald | Overweight |
| 2024-08-13 | 開始されました | Jefferies | Buy |
| 2024-08-13 | 開始されました | Needham | Buy |
| 2024-08-13 | 開始されました | TD Cowen | Buy |
| 2024-08-13 | 開始されました | Wedbush | Outperform |
すべてを表示
Artiva Biotherapeutics Inc (ARTV) 最新ニュース
Artiva Biotherapeutics Inc (ARTV) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Artiva Biotherapeutics Inc (ARTV) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
TradingKey - TradingKey
Insider Stock Purchases: July 24, 2026 - Quiver Quantitative
Thursday’s insider buys and sells: Artiva, StoneX and CoreWeave By Investing.com - Investing.com South Africa
Ra capital management, director, buys $58,306 of Artiva stock - Investing.com UK
Artiva Biotherapeutics Inc (ARTV) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
RA Capital Management acquires USD 2.62 million of Artiva Biotherapeutics common shares - Bitget
Form 4 Artiva Biotherapeutics Inc For: 23 July By Investing.com - Investing.com Nigeria
Form 13D/A ARTIVA BIOTHERAPEUTICS For: 23 July By Investing.com - Investing.com Nigeria
Ra capital management, director, buys $58,306 of Artiva stock By Investing.com - Investing.com Canada
Ra Capital Management buys $2.58m in Artiva Biotherapeutics stock By Investing.com - Investing.com Canada
Ra Capital Management buys $2.58m in Artiva Biotherapeutics stock - Investing.com
ARTV Options Volatility — NASDAQ:ARTV - TradingView
ARTV Options Chain — NASDAQ:ARTV - TradingView
Artiva Biotherapeutics Sets Deadline for 2026 Meeting - TipRanks
Artiva sets 2026 annual meeting for Sept. 8; stockholder notice deadline Aug. 1 - TradingView
Artiva Biotherapeutics (Nasdaq: ARTV) details 2026 meeting deadlines - Stock Titan
Major Insider Move Signals Growing Confidence in Artiva Biotherapeutics - TipRanks
New Form 4 - Moomoo
Artiva Biotherapeutics Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times
Form 4 Artiva Biotherapeutics Inc For: 14 July By Investing.com - Investing.com Nigeria
Ra Capital Management funds buy $194k in Artiva Biotherapeutics stock By Investing.com - Investing.com South Africa
Ra Capital Management funds buy $194k in Artiva Biotherapeutics stock - Investing.com
ARTV Q1 2026 Earnings: EPS Misses Estimates Amid Pre-Revenue Development StageProfit Announcement - DonanımHaber
Is Artiva Biotherapeutics, Inc. (ARTV) outperforming other medical stocks this year? - MSN
Is Artiva Biotherapeutics, Inc. (ARTV) Outperforming Other Medical Stocks This Year? - Yahoo Finance
What date does Artiva Biotherapeutics, Inc.'s (ARTV) report EarningsEarnings Calendar & Announcement - Zacks Investment Research
ARTV Q1 2026 Earnings: Wider-than-Expected Loss Weighs on SharesProduct Revenue Analysis - dars.gov.et
Artiva Biotherapeutics Q1 2026 Earnings: Wider-than-Expected Loss Highlights Pipeline Burn RatePost-Earnings Drift - dars.gov.et
Artiva Biotherapeutics (ARTV) Slips Near Key Support Level; Traders Eye $9.13 FloorImbalance Zone - dars.gov.et
Artiva Biotherapeutics at H.C. Wainwright: allogeneic cell therapy push By Investing.com - Investing.com Canada
Artiva Biotherapeutics (ARTV) Gains Ground With Support Holding at $9.21SuperTrend Flip - dars.gov.et
Major Stake Boost Signals Growing Confidence in Artiva Biotherapeutics - TipRanks
Ra capital funds buy $292k Artiva Biotherapeutics stock in late June - Investing.com South Africa
Artiva Biotherapeutics, Inc.(NasdaqGM: ARTV) added to Russell 2000 Index - marketscreener.com
Form 4 Artiva Biotherapeutics Inc For: 29 June By Investing.com - Investing.com South Africa
Artiva Biotherapeutics, Inc.(NasdaqGM: ARTV) added to Russell 2500 Growth Benchmark - marketscreener.com
Artiva Biotherapeutics, Inc.(NasdaqGM: ARTV) added to Russell 2000 Value Benchmark - marketscreener.com
Artiva Biotherapeutics, Inc.(NasdaqGM:ARTV) added to Russell Microcap Growth Benchmark Index - marketscreener.com
Artiva Biotherapeutics, Inc.(NasdaqGM: ARTV) added to Russell 2000 Growth Benchmark - marketscreener.com
Artiva Biotherapeutics, Inc.(NasdaqGM: ARTV) added to Russell 3000E Growth Benchmark - marketscreener.com
Artiva Biotherapeutics, Inc.(NasdaqGM:ARTV) added to Russell Small Cap Comp Value Benchmark - marketscreener.com
Price to sales forward of Artiva Biotherapeutics, Inc. – NASDAQ:ARTV - TradingView
Price to book forward of Artiva Biotherapeutics, Inc. – NASDAQ:ARTV - TradingView
Enterprise value to revenue forward of Artiva Biotherapeutics, Inc. – NASDAQ:ARTV - TradingView
Artiva Biotherapeutics, Inc.(NasdaqGM: ARTV) added to Russell 3000 Value Benchmark - marketscreener.com
Enterprise value to EBITDA forward of Artiva Biotherapeutics, Inc. – NASDAQ:ARTV - TradingView
Price to earnings forward of Artiva Biotherapeutics, Inc. – NASDAQ:ARTV - TradingView
Artiva Biotherapeutics, Inc. advances AlloNK therapy toward Phase 3 in autoimmune disease - Traders Union
Artiva Biotherapeutics Inc (ARTV) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Artiva Biotherapeutics Inc (ARTV) 財務データ
収益
当期純利益
現金流量
EPS
1.97%
0.83%
大文字化:
|
ボリューム (24 時間):